20 years' experience of eculizumab and ravulizumab therapy in 509 patients with paroxysmal nocturnal haemoglobinuria

被引：0
|
作者：
Holt, Matthew [1 ]
Kelly, Richard J. [1 ]
Vidler, Jennifer [2 ]
Arnold, Louise [1 ]
Large, Joanna [2 ]
Forrest, Briony [1 ]
Barnfield, Catherine [1 ]
Pike, Alexandra [1 ]
Griffin, Morag [1 ]
Munir, Talha [1 ]
Muus, Petra [1 ]
Nagumantry, Sateesh [3 ]
Trikha, Roochi [2 ]
Kulasekararaj, Austin [2 ]
Mitchell, Lindsay [4 ]
Gandhi, Shreyans [2 ]
机构：
[1] St James Univ Hosp, Leeds, W Yorkshire, England
[2] Kings Coll Hosp London, London, England
[3] Peterborough City Hosp, Peterborough, England
[4] Univ Hosp Monklands, Airdrie, Scotland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH23-OR29
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria
    Thomas O’Connell
    Marric Buessing
    Scott Johnson
    Lufei Tu
    Simu K. Thomas
    Ioannis Tomazos
    PharmacoEconomics, 2020, 38 : 981 - 994
  • [32] Pregnancy outcomes in women receiving eculizumab for the management of paroxysmal nocturnal haemoglobinuria
    Anderson, Rachel
    Manning, James
    Hill, Anita
    Ciantar, Etienne
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 132 : 33 - 33
  • [33] Eculizumab (Soliris®): a promising treatment of haemolytic anaemia in paroxysmal nocturnal haemoglobinuria
    Waldner, B.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S362 - S362
  • [34] Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab
    Niitsuma-Sugaya, Ikumi
    Kanamori, Hajime
    Ichikawa, Satoshi
    Fukuhara, Noriko
    Seike, Issei
    Takei, Kentaro
    Baba, Hiroaki
    Oshima, Kengo
    Aoyagi, Tetsuji
    Harigae, Hideo
    Tokuda, Koichi
    LANCET INFECTIOUS DISEASES, 2021, 21 (05): : 741 - 741
  • [35] COST-UTILITY ANALYSIS OF RAVULIZUMAB COMPARED WITH ECULIZUMAB IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    OConnell, T.
    Buessing, M. G.
    Johnson, S. J.
    Tu, L.
    Tomazos, I
    Thomas, S. K.
    VALUE IN HEALTH, 2019, 22 : S341 - S341
  • [36] Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria
    O'Connell, Thomas
    Buessing, Marric
    Johnson, Scott
    Tu, Lufei
    Thomas, Simu K.
    Tomazos, Ioannis
    PHARMACOECONOMICS, 2020, 38 (09) : 981 - 994
  • [37] SUCCESSFUL PREGNANCY OUTCOME IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ON LONG TERM ECULIZUMAB
    Kelly, R.
    Arnold, L. M.
    Richards, S. J.
    Hill, A.
    Bomken, C.
    Hanley, J.
    Loughney, A.
    Beauchamp, J.
    Khursigara, G.
    Rother, R. P.
    Chalmers, E.
    Gartnavel, A. Fyfe
    Fitzsimons, E.
    Nakamura, R.
    Gaya, A.
    Rotoli, B.
    Risitano, A.
    Schubert, J.
    Hillmen, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 452 - 452
  • [38] Pregnancy outcomes in women receiving eculizumab for the management of paroxysmal nocturnal haemoglobinuria
    Manning, James E.
    Anderson, Rachel M.
    Hill, Anita
    Zeidan, Doaa
    Ciantar, Etienne
    OBSTETRIC MEDICINE, 2022, 15 (01) : 45 - 49
  • [39] Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab
    Tomazos, Ioannis
    Sierra, J. Rafael
    Johnston, Karissa M.
    Cheung, Antoinette
    Brodsky, Robert A.
    Weitz, Ilene C.
    HEMATOLOGY, 2020, 25 (01) : 327 - 334
  • [40] Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria
    Macrae, F.
    Bowman, P.
    Linton, E.
    Peacock-Young, B.
    Clarke, D.
    Newton, D.
    McKinley, C.
    Riley, K.
    Copeland, N.
    Arnold, L.
    Ariens, R.
    Hill, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 130 - 130
12345